CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Hetero Labs Limited (Unit V) recalls Pantoprazole Sodium

Read the official FDA notice

Published
29 Apr 2026
Units affected
4,740 1,000-count bottles.
Agency
FDA
Country
United States

The hazard

Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherta, Mahabubager-509 301, India, NDC 31722-713-10

Brand / company
Hetero Labs Limited (Unit V)
Codes / lots
Batch # FD253967, Exp Date: 06/26/2027
Distribution
Nationwide in the USA.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 29 Apr 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.